TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A 2026 paper in The Lancet Healthy Longevity argues that sarcopenia and age-related mobility loss should be understood as problems of the wider motor system, not muscle alone. The authors say the approach needs testing: it has not been shown that proposed assessment measures improve outcomes or reduce costs.
Researchers writing in The Lancet Healthy Longevity have proposed that sarcopenia—age-related loss of strength and physical function—be understood as a problem of the wider motor system, not muscle alone. The argument could affect how clinicians assess older adults with weakness, but the authors say their proposed measures have not yet been shown to outperform current screening or improve patient outcomes.
The paper, by Lucas B. R. Orssatto and colleagues, says declining muscle mass explains only a modest share of strength loss in older adults. People with similar amounts of muscle can have different strength and mobility, the authors note, while exercise can improve strength and movement even when measured muscle mass does not change.
The authors describe the motor system as the network involved in producing movement, including the brain, spinal cord, nerves and muscles. Aging can affect how movement is planned, how reliably nerve signals reach muscles, and balance and awareness of body position. In this account, weakness may reflect impaired communication and coordination as well as reduced muscle.
They propose retaining measures such as grip strength and walking speed while exploring additional observations: how quickly a person rises from a chair, whether they become unsteady during sustained effort, changes in hand dexterity, and difficulty walking while talking. They also recommend closer examination when weakness is asymmetric, develops rapidly or seems out of proportion to muscle loss. These are proposals, not validated replacements for existing assessments.
A Broader Approach to Mobility Loss
The proposed shift matters because a muscle-only focus may not explain why people with similar muscle mass have markedly different abilities in daily life. If weakness also reflects changes elsewhere in the motor system, assessment and treatment could eventually be tailored to the source of a person’s difficulty rather than aimed mainly at increasing muscle mass.
The issue has consequences for falls, disability and independence. Medical Xpress reported that sarcopenia affects up to 29% of community-dwelling older adults, with higher rates in hospital and residential care and among people with frailty or multiple health conditions. The article also cited Australian figures: 253,800 fall-related hospitalizations in 2024–25, and 6,722 deaths following falls in the prior year. Those figures describe the burden of falls; they do not show that the proposed motor-system framework would prevent them.
The authors argue that research and health-care investment should evaluate approaches that address strength and everyday function, rather than relying predominantly on strategies to build muscle. Whether that change would produce better results remains untested.
Products Worth Considering
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
Withings Sleep Under-Mattress Sleep Tracking Pad
Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Navy
As an affiliate, we earn on qualifying purchases.
From Muscle Mass to Function
Clinical definitions of sarcopenia have already moved beyond muscle mass alone. According to the paper summarized by Medical Xpress, measures such as grip strength, gait speed and chair stands are used because they predict outcomes including falls, disability and death more effectively than muscle mass does. The authors say, however, that the explanation for weakness in clinical practice and research has often continued to center on muscle wasting.
Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm to guide primary-care screening, assessment and management of poor muscle health. The Lancet Healthy Longevity paper adds a challenge to that work: how to identify what is driving an individual’s weakness, rather than assuming muscle loss is the sole cause. The authors set out a five-point agenda for international groups that develop diagnostic criteria, though the supplied report does not detail each point.
“Nobody has yet shown that these measures beat existing screens, either on outcomes or on cost.”
— The authors, as summarized by Medical Xpress
Tests Still Need Validation
The paper presents a framework and research agenda, not proof that motor-system assessments lead to better care. The authors say it is not known whether the proposed measures outperform current screens on patient outcomes or cost. The report also does not establish which patients would benefit most from the approach or how it should change treatment in practice.
Access to clinicians with neuromuscular expertise is uneven, according to the authors. It also remains unclear which proposed tests could be used reliably in ordinary primary care, and whether measures of nerve and movement function would add useful information beyond existing assessments. These questions require validation studies and trials.
Research Needed Before Practice Changes
The authors are calling for practical assessment tools to be tested, guidelines that support a staged assessment approach, and trials that measure nerve function as well as muscle. International working groups that set diagnostic criteria are a stated audience for their five-point agenda.
Until evidence shows whether the proposed approach improves outcomes or offers value for its cost, the paper does not establish a new clinical standard. The next milestone is research that tests whether a broader motor-system assessment can help clinicians identify causes of weakness and preserve mobility and independence.
Key Questions
What is sarcopenia?
Sarcopenia is age-related loss of muscle, strength and physical function. The paper argues that muscle loss alone does not explain all weakness and mobility decline.
What does it mean to call sarcopenia a motor-system disease?
It means considering the brain, spinal cord, nerves and muscles involved in movement, rather than focusing only on muscle. The authors present this as a proposed framework, not an established change in diagnosis.
What assessments do the researchers suggest?
They suggest keeping measures such as grip strength and walking speed while studying observations including the speed of rising from a chair, unsteadiness during effort, hand dexterity and walking while talking. These measures have not been shown to outperform existing screens.
Does the paper show that the approach prevents falls?
No. The paper argues for a broader way to understand weakness, but the authors say the proposed measures have not been shown to improve outcomes. The report does not establish that this approach prevents falls.
Source: medicalxpress.com
